Search results
US FDA pushes decision on Moderna’s RSV vaccine to end of this month
KFGO· 5 days ago(Reuters) - The U.S. Food and Drug Administration has pushed back its decision on Moderna's...
Moderna Says FDA Delaying Decision on RSV Vaccine Approval
Bloomberg· 5 days agoHave a confidential tip for our reporters? US regulators’ decision on whether to approve Moderna...
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 5 days agoThe company said the FDA cited administrative constraints for the delay, and that the agency is working to complete its review of mRNA-1345 by the end of the month. Moderna
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 5 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 5 days ago"Although regulatory delays are disappointing and usually create noise around the probability of...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoThe agency, citing administrative constraints, does not expect to complete its review of the Biologics License Application (BLA) for mRNA-1345, Moderna’s investigational respiratory ...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoIf the lofty claims made by others in the biotech industry are true, the company could see a...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 5 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 5 days agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 5 days agoModerna (NASDAQ:MRNA) shares are down just over 1% in early Friday trading after the company said...